Status:
UNKNOWN
Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients
Lead Sponsor:
Federation of Breast Diseases Societies
Conditions:
Breast Cancer
Metastasis
Eligibility:
FEMALE
18+ years
Brief Summary
The number of intervention performed for metastatic breast cancer has dramatically increased over the past 2 decades. Hepatectomy and pulmonary resection for stage IV colorectal cancer is now consider...
Detailed Description
Purpose Despite breast cancer being the most common cancer in women in the developed world, only a minority of patients (\< 10%) has stage IV disease at diagnosis (1). In addition, 20-30% of patients ...
Eligibility Criteria
Inclusion
- Metastatic breast cancer (lung and/or hepatic metastasis) 18 years and older Antineoplastic treatment
Exclusion
- No lung and/or hepatic metastasis Below 18 years No antineoplastic treatment
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02251353
Start Date
June 1 2014
End Date
June 1 2022
Last Update
February 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University Istanbul Medical Faculty
Istanbul, Turkey (Türkiye)